Assay name | Assay description | Volume required (uL) |
a-SMA | Acetylated N-terminal of alpha-smooth muscle actin | 50 |
BGM | Neo-epitope of MMP-9,12 mediated degradation of biglycan | 50 |
DCN-CS | Cathepsin S mediated decorin degradation | 50 |
HSP47-C | C-terminal of heat shock protein-47 | 50 |
LAM | Neo-epitope of MMP-9 mediated degradation of laminin alpha 5 chain | 50 |
LG1M | Neo-epitope of MMP-9 mediated degradation of laminin gamma 1 chain | 50 |
MIM | Neo-epitope of MMP-9,12 mediated degradation of mimecan | 50 |
NIC | Neo-epitope of cathepsin-S mediated degradation of nidogen | 50 |
SPARC-M | Neo-epitope of MMP mediated degracation of SPARC | 50 |
TIM | Neo-epiotpe of MMP-12 mediated degradation of titin (Cardiac isoform) | 50 |
TIM-2 | Specific fragment of MMP-12-mediated degradation of titin (Muscle isoform) | 50 |
VCANM | Neo-epitope of MMP-8,12 mediated degradation of versican | 50 |
VICM | Neo- epitope of MMP-2, 8 and trypsin mediated degradation of citrullinated vimentin | 50 |
ARGS | N-terminal epitope of Aggrecanase mediated degradation of aggrecan | 50 |
FBN-C | C-terminal of fibronectin
| 50 |
CPa9-HNE | Neo-epitope fo human neutrophil elastase (HNE) mediated degradatib if calprotectin
| 50 |
PROM | Neo-epitope of MMP-1 and -13 mediated degradation of prolargin | 50 |
uPerla | Neo-epiotpe of ADAMTS mediated degradation of perlecan | 50 |
exAGNxI | Neo-epitope of aggrenase mediated aggrecan | 50 |
exFFGV | Neo-epitope of MMP mediated aggrecan | 50 |
BREM | Brevican degraded by MMPs | 50 |
BREV-A | Neo-epitope of ADAMTS-4 mediated degradation of brevican | 50 |
n-BREV | N-terminal of brevican | 50 |
TAU-A | Neo-epitope of ADAM-10 mediated degradation of TAU | 50 |
TAU-C | Neo-epitope of caspase-3 mediated degradation of TAU | 50 |
exMMP3 | Activated MMP-3 | 50 |
acCAT-K | Activated Cathepsin K | 50 |
acMMP-9 | Activated MMP-9 | 50 |
acMMP-13 | N-terminal of active MMP-13 | 50 |
acADAMTS4 | N-terminal of active ADAMTS-4 | 50 |
acADAMTS5 | N-terminal of active ADAMTS-5 | 50 |
COMP-N | N-terminal of COMP | 50 |
SPARC-C | C-terminal of SPARC | 50 |
AGR-N | N-terminal of agrin | 50 |
FBN-EDA | Neo-epitope of MMP-8 mediated degradation of cellular fibronectin (EDA domain) | 50 |
FMODM | Fibromodulin degraded by MMP-12 | 50 |
Assay name | Assay description | Volume required (uL) |
GDF-8 | Myostatin (growth/differentiation factor 8) | 150 |
IL-6 | Interleukin-6 | 250 |
FMODM | Fibromodulin degraded by MMP-12 | 50 |
Ostase BAP | Bone-specific Alkaline Phosphatase ELISA | 100 |
PIIANP | Type IIA Collagen N-Propeptide (PIIANP) ELISA | 10 |
C-P-Tau (181P) | Phosphorylated Tau (P181) | 50 |
C-β-Amyloid (1-42) | Amyloid Beta 1-42 | 50 |
HCG | Chorionic Gonadotropin (pregnancy test) | 10 |
PTH, intact | Parathyroid hormone | 50 |
S-Free T4 | thyroxine | 15 |
S-Testosterone | testosterone | 20 |
S-Total T3 | Total triiodothyronine | 30 |
S-TSH | thyroid stimulating hormone | 50 |
Total PINP | N-terminal pro-peptide of type I collagen | 20 |
Anti-CCP | Anti-citrullinated protein antibodies | 15 |
Anti-HCV | Antibodies to hepatitis C virus | 50 |
HBsAg II | Hepatitis B surface antigen | 50 |
HIV combi PT | HIV-1 P24 antigen, antibodies against HIV-1 and HIV-2 | 40 |
HIV-Ag | HIV-1 P24 antigen group M and O | 50 |
Insulin | Insulin | 20 |
S-Albumin | Albumin | 2 |
S-ALAT | Alanine transaminase | 25 |
S-ASAT | Aspartate transaminase | 25 |
S-Bilirubin | Total billirubin | 14.3 |
S-Calcium | Serum calcium | 16 |
S-Cholesterol | Serum cholesterol | 4 |
S-Creatinine | Serum creatinine | 24 |
S-GGT | Gamma-glutamyltransferase | 10 |
S-Glucose | Glucose | 3.4 |
S-protein | Total serum protein | 17.5 |
S-Urea | Serum urea | 7 |
S-HDL Cholesterol | Serum HDL cholesterol | 5 |
S-LDL Cholesterol | Serum LDL cholesterol | 5 |
Urine Calcium | Urine calcium | 16 |
Urine Creatinine | Urine Creatinine | 24 |
Urine Phosphat | Urine Phosphat | 8 |
S-Phosphat | Serum phosphat | 8 |
S-Magnesium | Serum magnesium | 12 |
S-Lipase | Serum lipase | 3 |
S-Amylase | Serum amylase | 16 |
S-LDH | Serum LDH | 14 |
S-CO2 | Serum CO2 | 6 |
ELF | 65 |
